Retrolaminar block and erector spine block given to a patient in Percutaneous nephrolithotomy operation for pain management

Analgesic efficacy of Retrolaminar block with Erector Spinae plane block in adult patients undergoing Percutaneous nephrolithotomy surgery: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050668

Enrollment

Registered

2023-03-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: receive Retrolaminar Block: Group I: will receive Retrolaminar Block at T9 level Bupivacaine 0.125% volume 20ml NRS Assesss :24 hour Control Intervention1: ESP Block: Group II: ESP B

Eligibility

Inclusion criteria

Inclusion criteria: ASA I/II Age (Either Sex) â?? 17 to 65 years Scheduled for PCNL

Exclusion criteria

Exclusion criteria: Mental disorder Communication failure Inability to understand the functionality of patient-controlled analgesia pump

Design outcomes

Primary

Measure	Time frame
To compare the requirement of perioperative analgesics (total dose of Nalbuphine )Timepoint: 24 hour	—

Secondary

Measure	Time frame
To determine time of first rescue analgesic administration To measure average pain NRS score at 24 h postoperatively period (30 min, 2 hour, 4 hour, 8 hour, 12 hour, 24 hour) To measure any adverse effect Timepoint: 24 hour	—

Countries

India

Contacts

Public ContactDr Poonam Kumari

All India Institute of Medical Sciences, Patna

drpoonam1981@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026